Robert Wood Johnson University Hospital (RWJUH) Somerset, an RWJBarnabas Health facility, was recognized as “high performing” in the treatment of five procedures and conditions in U.S. News & World Report’s 2021-2022 Best Hospitals rankings and ratings which were released today. The hospital was recognized for the treatment of Chronic Obstructive Pulmonary Disease (COPD), diabetes, heart failure, kidney failure and stroke.
“Our commitment to quality underpins everything we do,” said Tony Cava, president and CEO, RWJUH Somerset. “These recognitions are a testament to the dedication and expertise of our entire team. Our community can be assured that they have access to leading-edge medical care close to home.”
RWJUH Somerset also recently received the 2021 Healthgrades Patient Safety Excellence Award, ranking in the top 5% in the nation for patient safety. In addition, the hospital earned an “A” Hospital Safety Score – the highest patient safety rating – from the Leapfrog Group this spring. It was the hospital’s sixth consecutive “A” rating and twelfth overall.
The hospital has earned the Joint Commission’s Gold Seal of Approval for total knee and total hip replacement surgery; acute myocardial infarction and stroke and is designated as a Primary Stroke Center by the Joint Commission and the New Jersey Department of Health and Senior Services.
RWJUH Somerset’s Steeplechase Cancer Center has been nationally accredited by the Commission on Cancer. For six years in a row, the hospital has been named a Leader in LGBTQ Healthcare Equality by the Human Rights Campaign Foundation.
For more information about Robert Wood Johnson University Hospital Somerset, visit www.rwjbh.org/somerset.